HIT Consultant September 7, 2022
Sobha Pisharody, PhD, Chief Strategy & Product Officer, InformedDNA

Pharmacogenomics—the study of genetic influences on an individual’s response to therapeutic medications—is an area of personalized medicine that is gaining momentum. Although pharmacogenomics has been around for a while, providers, health plans, pharmacists and legislators are developing a greater appreciation for its potential benefits and applications.

How Can Pharmacogenomics Improve Outcomes?

By considering a person’s DNA in treatment options, providers can determine how an individual’s genetic profile may impact the way the individual could respond to specific therapies. For example, certain gene changes may indicate a person is a high metabolizer and thus may require a higher starting dose of medication to have a therapeutic effect. Alternatively, other gene changes may indicate a low metabolizer status, which may indicate...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Interview / Q&A, Pharma / Biotech, Precision Medicine, Trends
Putting Patients First by Extending the Reach of World-Class Care
Healthcare's most promising tech
AI In Healthcare: A New Era Of Personalized Patient Care
23andMe reports sales decline a day after announcing plans to cut 40% of workforce
Patient-derived organoids: Transforming cancer research and personalized medicine

Share This Article